About Inspirata
Inspirata is a leading oncology informatics company that provides end-to-end cancer registry automation solutions for healthcare organizations. With over 20 years of industry innovation, the company serves 270+ hospitals and processes more than 30 million pathology, radiology, and related clinical reports annually. Inspirata's flagship products, E-Path and E-Path Plus, leverage proprietary AI and Natural Language Processing (NLP) technology to automate the most time-intensive aspects of cancer registry management—casefinding and data abstraction. The platform identifies reportable cancer cases in real-time with 98-99% validated accuracy, reducing manual processing time from 30-45 minutes per report to seconds. E-Path Plus auto-populates abstracts with 124+ oncology-specific data elements directly from unstructured clinical documents, allowing oncology data specialists to focus on quality assurance rather than repetitive data entry. Through an exclusive partnership with ONCO, Inspirata delivers the industry's only unified workflow from initial clinical report to final state and federal submission. The company's solutions are deployed on-premises to ensure maximum security and HIPAA compliance, with seamless integration into major EHR, LIS, and RIS systems. Inspirata serves academic medical centers, comprehensive cancer centers, NCI-designated cancer centers, oncology departments, and community oncology practices. The platform addresses critical operational challenges including staffing shortages, registry backlogs, and accreditation requirements while unlocking cancer data for clinical research, trial matching, and patient navigation. With a 96% customer retention rate, Inspirata has established itself as the trusted partner for healthcare organizations seeking to transform their cancer registries from compliance burdens into strategic data assets that drive improved patient outcomes and operational efficiency.
Clinical Focus
Medical conditions and clinical areas addressed by Inspirata.
Who It Serves
Milestones & Awards
Recent Milestones
Exclusive partnership with ONCO to provide unified end-to-end cancer data platform combining Inspirata AI's technology with ONCO's registry software and services
Awards & Recognition
20+ years leading industry innovation in oncology informatics
Key Partnerships
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 45 →
Aiforia
Aiforia provides AI-powered digital pathology solutions for clinical diagnostics and research. The company offers cloud-based deep learning tools and CE-IVD marked clinical suites for analyzing pathology images across multiple cancer types, serving pathologists, researchers, and diagnostic laboratories worldwide.
Aignostics
Aignostics develops AI-powered pathology solutions for precision medicine, specializing in tumor microenvironment analysis from H&E-stained whole slide images. The company serves life sciences companies and academic researchers with foundation models and custom analytics services.
Aiosyn
Aiosyn develops AI-powered computational pathology software that integrates into standard digital pathology workflows. The company specializes in deep learning solutions for cancer and chronic kidney disease diagnostics, serving clinical laboratories, biopharma, and CROs.
AIxMed
AIxMed develops AI-powered computational cytology platforms for cancer detection and diagnosis. The company's flagship product AIxURO analyzes urine cytology for bladder cancer, with additional platforms in development for thyroid, cervical, and lung cancer screening.
Akoya Biosciences
Akoya Biosciences, now part of Quanterix, provides spatial biology solutions for high-plex tissue analysis. The company develops instruments, assays, and software for spatial proteomics research, enabling researchers to map biomarkers at single-cell resolution in tissue samples.
Caris Life Sciences
Caris Life Sciences is a leading precision medicine company that provides comprehensive molecular profiling for cancer patients. The company combines genomic, transcriptomic, and proteomic data with AI to deliver personalized treatment insights for oncologists and patients.
CellaVision
201-500 employees
CellaVision is a world-leading provider of digital hematology microscopy solutions covering analyzers, instruments, reagents, and software. The company automates workflows in hematology laboratories of all sizes for human and animal blood and body fluid sample analysis.
Clever Culture Systems
Clever Culture Systems develops AI-powered automated microbiology culture plate reading technology for pharmaceutical and clinical laboratories. Their flagship product, APAS Independence, automates the imaging, interpretation, and reporting of microbial growth on culture plates.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.